Aryal R, Ramanujan A, Bucci C, Neckelmann C, Heimburg-Molinaro J, Cummings S
J Inherit Metab Dis. 2025; 48(2):e70006.
PMID: 39949072
PMC: 11826066.
DOI: 10.1002/jimd.70006.
Novak J, King R, Yother J, Renfrow M, Green T
Glycobiology. 2024; 34(11).
PMID: 39095059
PMC: 11442006.
DOI: 10.1093/glycob/cwae060.
Zemkollari M, Oostenbrink C, Grabherr R, Staudacher E
Glycobiology. 2024; 34(4).
PMID: 38366999
PMC: 11005171.
DOI: 10.1093/glycob/cwae013.
Festari M, Jara E, Costa M, Iriarte A, Freire T
Sci Rep. 2024; 14(1):1809.
PMID: 38245559
PMC: 10799929.
DOI: 10.1038/s41598-024-52204-2.
Tumoglu B, Keelaghan A, Avci F
Glycobiology. 2023; 33(11):879-887.
PMID: 37847609
PMC: 10859631.
DOI: 10.1093/glycob/cwad083.
Large-Scale and Site-Specific Mapping of the Murine Brain -Glycoproteome with IMPa.
Suttapitugsakul S, Matsumoto Y, Aryal R, Cummings R
Anal Chem. 2023; 95(36):13423-13430.
PMID: 37624755
PMC: 10501376.
DOI: 10.1021/acs.analchem.3c00408.
Potential immunosuppressive clonal hematopoietic mutations in tumor infiltrating immune cells in breast invasive carcinoma.
Anandakrishnan R, Zyvoloski I, Zyvoloski L, Opoku N, Dai A, Antony V
Sci Rep. 2023; 13(1):13131.
PMID: 37573441
PMC: 10423211.
DOI: 10.1038/s41598-023-40256-9.
Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins.
Aasted M, Groen A, Keane J, Dabelsteen S, Tan E, Schnabel J
Mol Cancer Ther. 2023; 22(10):1204-1214.
PMID: 37451822
PMC: 10543972.
DOI: 10.1158/1535-7163.MCT-23-0221.
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy.
Czajka-Francuz P, Prendes M, Mankan A, Quintana A, Pabla S, Ramkissoon S
Front Oncol. 2023; 13:1200646.
PMID: 37427115
PMC: 10325690.
DOI: 10.3389/fonc.2023.1200646.
Deciphering Protein O-GalNAcylation: Method Development and Disease Implication.
Yue S, Wang X, Ge W, Li J, Yang C, Zhou Z
ACS Omega. 2023; 8(22):19223-19236.
PMID: 37305274
PMC: 10249083.
DOI: 10.1021/acsomega.3c01653.
Germline mutation causes a multisystem chaperonopathy.
Erger F, Aryal R, Reusch B, Matsumoto Y, Meyer R, Zeng J
Proc Natl Acad Sci U S A. 2023; 120(22):e2211087120.
PMID: 37216524
PMC: 10235935.
DOI: 10.1073/pnas.2211087120.
Proteomic cardiovascular risk assessment in chronic kidney disease.
Deo R, Dubin R, Ren Y, Murthy A, Wang J, Zheng H
Eur Heart J. 2023; 44(23):2095-2110.
PMID: 37014015
PMC: 10281556.
DOI: 10.1093/eurheartj/ehad115.
Comprehensive analysis of platelet glycoprotein Ibα ectodomain glycosylation.
Hollenhorst M, Tiemeyer K, Mahoney K, Aoki K, Ishihara M, Lowery S
J Thromb Haemost. 2023; 21(4):995-1009.
PMID: 36740532
PMC: 10065957.
DOI: 10.1016/j.jtha.2023.01.009.
Role of tumor cell sialylation in pancreatic cancer progression.
Marciel M, Haldar B, Hwang J, Bhalerao N, Bellis S
Adv Cancer Res. 2023; 157:123-155.
PMID: 36725107
PMC: 11342334.
DOI: 10.1016/bs.acr.2022.07.003.
X-linked C1GALT1C1 mutation causes atypical hemolytic uremic syndrome.
Hadar N, Schreiber R, Eskin-Schwartz M, Kristal E, Shubinsky G, Ling G
Eur J Hum Genet. 2023; 31(10):1101-1107.
PMID: 36599939
PMC: 10545727.
DOI: 10.1038/s41431-022-01278-5.
Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease.
Xiang T, Qiao M, Xie J, Li Z, Xie H
Biomolecules. 2022; 12(12).
PMID: 36551160
PMC: 9775496.
DOI: 10.3390/biom12121732.
A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis.
Bian C, Sun X, Huang J, Zhang W, Mu G, Wei K
Front Oncol. 2022; 12:950783.
PMID: 36059686
PMC: 9434379.
DOI: 10.3389/fonc.2022.950783.
A roadmap for translational cancer glycoimmunology at single cell resolution.
Peixoto A, Miranda A, Santos L, Ferreira J
J Exp Clin Cancer Res. 2022; 41(1):143.
PMID: 35428302
PMC: 9013178.
DOI: 10.1186/s13046-022-02335-z.
An etanercept O-glycovariant with enhanced potency.
Biel T, Faison T, Matthews A, Zou G, Ortega-Rodriguez U, Pegues M
Mol Ther Methods Clin Dev. 2022; 25:124-135.
PMID: 35402630
PMC: 8957051.
DOI: 10.1016/j.omtm.2022.03.002.
Update on the role of C1GALT1 in cancer.
Xia T, Xiang T, Xie H
Oncol Lett. 2022; 23(3):97.
PMID: 35154428
PMC: 8822393.
DOI: 10.3892/ol.2022.13217.